Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Lymphoma, Follicular 1 Carcinoma 1 Burkitt Lymphoma 1 Adenocarcinoma, Mucinous 1

Interventions

Cyclophosphamide 29 blinatumomab 19 Vincristine 16 Specimen Handling 13 Methotrexate 13 Dexamethasone 13 fludarabine 12 Prednisone 11 Cytarabine 11 Biopsy 11 Doxorubicin 9 Asparaginase 9 Rituximab 8 Mercaptopurine 8 Inotuzumab Ozogamicin 8 merphos 7 Spinal Puncture 7 N,N-dicyclohexyl-isoborneol-10-sulfonamide 7 Magnetic Resonance Spectroscopy 7 venetoclax 6 prednylidene 6 dexamethasone acetate 6 dexamethasone 21-phosphate 6 deltacortene 6 azathiopurine 6 auricularum 6 Etoposide 6 Daunorubicin 6 Calcium Dobesilate 6 pegaspargase 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Burkitt Lymphoma × Diphenhydramine × Clear all

NCT07570173 2026-05-26

MK-1045-005

Merck Sharp & Dohme LLC

Phase 2/3 Recruiting

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡